IMMP

Immutep Limited American Depositary Shares (IMMP)

About Immutep Limited American Depositary Shares (IMMP)

Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alpha (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731). The company was founded on May 21, 1987, and is headquartered in Sydney, Australia.

Details

Daily high

$2.09

Daily low

$2.02

Price at open

$2.06

52 Week High

$3.34

52 Week Low

$1.58

Market cap

298.2M

Dividend yield

0.00%

Volume

100,051

Avg. volume

137,272

P/E ratio

-8.84

Immutep Limited American Depositary Shares News